Back to search results

Team-Based Treatment for Pediatric Anxiety and OCD

This study is testing a team-based approach to deliver Cognitive Behavioral Therapy (CBT) for children and teens aged 5 to 18 with anxiety disorders or Obsessive Compulsive Disorder (OCD). CBT teaches skills to help you gradually face situations you fear. In this study, you would have weekly CBT sessions, including three visits a month with an exposure coach and one visit a month with a licensed provider (like a psychologist). The researchers want to see if this team-based method makes CBT more available and effective. Success will be measured by changes in anxiety and OCD symptoms, and how satisfied families are with the treatment. The study aims to enroll 501 participants, but its current recruitment status is unclear.

Study design
This is an interventional study with a planned enrollment of 501 participants. It is comparing different ways to deliver team-based, exposure-based CBT.
What's involved
You would have weekly CBT treatment sessions for 24 weeks, including three visits per month with an exposure coach and one visit per month with a licensed provider.
Compensation
Not stated in the trial record.
Follow-up
You would be followed for 6 and 12 months after treatment to assess your symptoms and satisfaction.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06934525

Testing Delivery Modalities of Team-Based CBT for Pediatric Anxiety in Community Health Settings.

Recruiting
NAAges 5–18InterventionalTreatment
Bradley Hospital
~501 participants
Updated 2026-07-31 on ClinicalTrials.gov
What's tested:Team-delivered, exposure-based CBT

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Top Problems Assessment- Caregiver report
Measured over Baseline, Week 8, Week 16 and follow-up (6 & 12 months)
+1 more outcome measured

Conditions

Obsessive Compulsive Disorder (OCD)
Pediatric Anxiety Disorders
Anxiety Disorder
Anxiety
OCD
Phobia
Agoraphobia
Generalized Anxiety
Generalized Anxiety Disorder
Selective Mutism
Separation Anxiety
Social Anxiety
Social Anxiety Disorder
Panic Disorder
Pediatric Disorders

Explore related trials

AgoraphobiaAnxiety DisorderGeneralized Anxiety DisorderObsessive Compulsive DisorderPanic DisorderPhobiaSelective MutismSeparation Anxiety DisorderSocial Anxiety Disorder

Where it's being run

1 sites across 1 states
Rhode Island1

Who to contact

Jennifer Freeman, PhD
[email protected]
401-432-1000
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 5-18 inclusive
Primary or co-primary DSM-V diagnosis of anxiety or OCD
Symptom duration of at least 3 months
Outpatient care needed
Presence of a stable parent, or guardian, who can participate in treatment

Exclusion

Other primary or co-primary psychiatric disorder which requires initiation of other active current treatment
Acute suicidality
Concurrent psychotherapy
Chronic medical illness that would preclude their active participation in treatment
Treatment with psychotropic medication that is not stable

What this trial measures

  • Top Problems Assessment- Caregiver reportBaseline, Week 8, Week 16 and follow-up (6 & 12 months)

    The TPA is designed to independently solicit from youth and parents the top 3 problems they feel are most important to address in treatment. This is an idiographic measure of impairment that is driven by the individual needs and desires of the consumer. Respondents rate how much each problem bothers them from 0 ("not at all") to 10 (very, very much).

  • Child Sheehan Disability Scale (CSDS)- caregiver reportBaseline, Week 8, Week 16 and follow-up (6 & 12 months)

    The CSDS measures the extent to which anxiety symptoms interfere with functioning. The Disability Scale measures the degree to which anxiety impacts school, social, and home life on a scale from 0 (Not at all) to 10 (very, very much.) Total anxiety-related impairment ranges from 0-30, with higher scores indicating greater impairment.